Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 55 results for "national pharmaceutical pricing autho..."

GST impact: Medicines for diabetes, cancer to get cheaper under new tax system
Money Today

GST impact: Medicines for diabetes, cancer to get cheaper unde...

Ahead of the GST rollout on July 1, the National Pharmaceutical Pricing Authority (NPPA) on Tuesday announced provisional ceiling prices of 761 medicines which includes a list of antibiotics and drugs for treating cancer, HIV, diabetes. "To facilitate smooth ... Money Today, 16 hours ago

40 images for national pharmaceutical pricing authority

Money Today, 15 hours ago, 4 months ago
Deccan Chronicle, 6 months ago
Money Control, 3 months ago, 8 months ago
Money Today, 4 months ago
Indian Express, 7 months ago
International Business Times India, 5 months ago
Pharmafile, 5 months ago
Indian Express, 8 months ago

NPPA issues memorandum to monitor prices of 19 medical devices

In a latest crackdown to curb high prices of medical devices, NPPA or the National Pharmaceutical Pricing Authority, India#39;s drugs pricing watchdog, has issued a memorandum to monitor prices of 19 medical devices sold.
 Money Control1 month ago No proposal to extend price cap to other medical devices, says NPPA chief  Business Standard2 months ago NPPA finalises format to monitor price of 19 medical devices  Business Standard1 month ago
Med India

Regulator to act against drug firms for violating pricing norms

The National Pharmaceutical Pricing Authority (NPPA) will take action against 200 pharma companies, which launched new formulations or drugs without its approval of prices, said the regulator on Thursday."We have decided to take action against those (200) ...
 Prokerala1 month ago Drug Firms to Face Action for Violations in Pricing Norms  Med India1 month ago

EU tests limits of drug pricing freedom in landmark probe

By Foo Yun Chee and Ben Hirschler BRUSSELS/LONDON (Reuters) - The first ever EU antitrust probe into excessive drug pricing is taking the European pharmaceuticals industry into uncharted territory, unnerving some companies and lawyers worried about the reach ...
 Sify2 days ago Drug pricing regulator clamps down on drug cocktails  Sify1 month ago UPDATE 1-India's drug pricing regulator clamps down on drug cocktails  Sify1 month ago

Dr Reddy's sees no impact from pricing regulator notice

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, said it expects no impact from a recent government notice that said the company is selling a high blood pressure drug that lacks the pricing regulator's approval. India's drug pricing ...
 Sify1 month ago

Is Niti Aayog pursuing anti-poor agenda?

The most recent face-off between the SJM and the Aayog has been over the drug pricing control regime. The Swadeshi Jagran Manch (SJM), an economic policy think tank affiliated to the Rashtriya Swayamsevak Sangh, has accused the NITI Aayog and bureaucrats of three key central ministries of trying to sabotage the prime minister’s vision of making medicines accessible to the poor at affordable prices. In a letter to the PM, the SJM has accused the NITI Aayog of pursuing an agenda that is ...
 Rediff.com1 month ago

Sensex Finishes Down by 206 Points; Pharma Stocks Lead the Losses

Posted by Equitymaster Indian share markets continued to trade witness selling pressure in the afternoon session. At the closing bell, the BSE Sensex stood lower by 206 points, while the NSE Nifty finished down by 52 points. Meanwhile, the S&P BSE Mid Cap and ...
 Equitymaster.com1 month ago Sensex, Nifty Finish Weak as U.S. Strikes Syria; Pharma Stocks Hit the Worst  Equitymaster.com2 months ago Sensex Finishes in Red for Fifth Consecutive Session; PSU Bank Stocks Tumble  Equitymaster.com1 day ago

Sensex Remains Buoyant; Pharma Stocks Lead Gains

Posted by Equitymaster After opening the day on a positive note, share markets in India have continued the momentum are trading near all-time highs. Apart from stocks in the oil and gas sector , all sectoral indices are trading on a positive note. Stocks in ...
 Equitymaster.com3 weeks ago Dull End to the Day; ABB Surges 10% on Q1 Results  Equitymaster.com1 month ago Sensex Trades in Red; PSU Stocks Witness Buying  Equitymaster.com2 months ago

Sensex Opens Flat; Sun Pharma Loses

Posted by Equitymaster Most Asian equity markets opened lower today. Stocks fell as soft US economic data added to investor concerns. The Shanghai Composite is off 0.94% while the Hang Seng is down 0.21%. The Nikkei 225 is trading lower by 0.31%. The US ...
 Equitymaster.com2 months ago Sensex Opens Flat; Automobile Stocks In Demand  Equitymaster.com1 month ago Sensex Opens in Green; FMCG Stocks Lead Gains  Equitymaster.com1 month ago Sensex Opens Up by 125 Points Led by Automobile & Bank Stocks  Equitymaster.com2 months ago

Global Share Markets End the Week on a Dull Note

Posted by Equitymaster Global financial markets ended the week on a dull note. This was on back of the Federal Reserve's release of its May 2-3 policy meeting minutes. After raising the benchmark interest rate by 25 basis points. The Fed seemed to be open to ...
 Equitymaster.com5 days ago Brazil Leads Global Market Rally on Hopes of Political Reform  Equitymaster.com1 month ago Global Stock Markets End on a Positive Note with Emerging Markets leading Gains  Equitymaster.com1 month ago French Presidential election and Oil Price Fall Impact Global Markets  Equitymaster.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less